An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)

Pulmonary sarcomatoid carcinoma (PSC) is an uncommon subtype of lung cancer, and immune checkpoint blockade promises in clinical benefit. However, virtually nothing is known about the expression of common immune checkpoints in PSC. Here, we performed immunohistochemistry (IHC) to detect nine immune-...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Haoyue, Li, Binglei, Diao, Li, Wang, Hao, Chen, Peixin, Jiang, Minlin, Zhao, Lishu, He, Yayi, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279095/
https://www.ncbi.nlm.nih.gov/pubmed/34290908
http://dx.doi.org/10.1080/2162402X.2021.1947665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279095/
https://www.ncbi.nlm.nih.gov/pubmed/34290908
http://dx.doi.org/10.1080/2162402X.2021.1947665

Ejemplares similares